Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Tradegate
23.04.25
16:48 Uhr
1,630 Euro
-0,076
-4,45 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,6541,72424.04.
1,6651,75224.04.

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiFOSUN PHARMA (02196): NOTIFICATION LETTER TO SHAREHOLDERS - NOTICE OF PUBLICATION OF 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) AND SUSTAINABILITY ...4
MiFOSUN PHARMA (02196): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) AND SUSTAINABILITY REPORT1
MiFOSUN PHARMA (02196): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2024-
MiFOSUN PHARMA (02196): NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 20242
MiFOSUN PHARMA (02196): ANNUAL REPORT 20243
DiChina's Fosun Pharma to Hike Stake in Henlius After Failed Privatization Bid; Shares Gain8
DiBRIEF: Fosun Pharma raises stake in Henlius3
15.04.FOSUN PHARMA (02196): DATE OF BOARD MEETING7
SHANGHAI FOSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln
11.04.FOSUN PHARMA (02196): CONNECTED TRANSACTION - DISPOSAL OF A PORTION OF EQUITY INTEREST IN SUBSIDIARY3
11.04.FOSUN PHARMA (02196): REPURCHASE AND CANCELLATION OF CERTAIN RESTRICTED SHARES UNDER THE 2022 RESTRICTED A SHARE INCENTIVE SCHEME2
08.04.FOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK4
07.04.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF DRUG CLINICAL TRIAL OF A SUBSIDIARY4
31.03.FOSUN PHARMA (02196): CONNECTED TRANSACTION - ENTERING INTO THE SHARE SUBSCRIPTION AGREEMENT5
27.03.Shanghai Fosun Pharmaceutical reports FY results5
26.03.FOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK10
26.03.Fosun Pharma Announces 2024 Annual Results242Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai...
► Artikel lesen
25.03.FOSUN PHARMA (02196): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20249
25.03.FOSUN PHARMA (02196): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 20242
25.03.FOSUN PHARMA (02196): VOLUNTARY ANNOUNCEMENT - REGISTRATION OF MEDIUM TERM NOTES AND SUPER SHORT-TERM COMMERCIAL PAPERS2
14.03.Fosun Pharma verkauft Anteil an Krankenhausgruppe für 124,08 Mio. US-Dollar an Warburg Pincus - Nikkei4
Seite:  Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1